
Journal of Medicinal Chemistry p. 8801 - 8815 (2017)
Update date:2022-08-15
Topics:
Kaitsiotou, Helena
Keul, Marina
Hardick, Julia
Mühlenberg, Thomas
Ketzer, Julia
Ehrt, Christiane
Krüll, Jasmin
Medda, Federico
Koch, Oliver
Giordanetto, Fabrizio
Bauer, Sebastian
Rauh, Daniel
In modern cancer therapy, the use of small organic molecules against receptor tyrosine kinases (RTKs) has been shown to be a valuable strategy. The association of cancer cells with dysregulated signaling pathways linked to RTKs represents a key element in
View MoreBeijing Zhongshuo Pharmaceutical T & D Co.,Ltd
Contact:0086-10-64430626
Address:ea No 16, HEPINGLI,DONGCHENG DISTRICT,BEIJING,P.R.CHINA.
Contact:0086-357-6662688
Address:Zhaocheng town, Hongtong County, Linfen City, Shanxi Province
SHANGHAI SYSTEAM BIOCHEM CO., LTD
website:http://www.systeambc.com
Contact:86-021-58380978
Address:Building 87,Lane 669, Dong Jing Road Shanghai,P.R.China
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Baoding City Light Industry And Textiles Imp.& Exp. Corp. Chemical Department.
Contact:86-312-3262436
Address:NO.658 CHAOYANG SOUTH STREET,BAODING CITY HEBEI CHINA
Doi:10.1016/j.tet.2007.03.044
(2007)Doi:10.1039/c6ob01198e
(2016)Doi:10.1007/s10593-011-0744-x
(2011)Doi:10.1007/BF00574792
(1984)Doi:10.1002/hlca.19490320130
(1949)Doi:10.1039/c2ob26828k
(2012)